Mojado, Sophia Zushiegn P.

HRN: 21-05-34  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/26/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/26/2022
05/02/2022
IV
140
Q6
PCAP
Waiting Final Action 
04/26/2022
CEFUROXIME 750MG (VIAL)
04/27/2022
05/03/2022
IV
185mg
Q8
PCAP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: